Informed-money record
MASI · MASIMO CORP
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
3
Bearish filings
3
Named actors
3
Disclosed $ (bull / bear)
$468K / $2.6M
Recent disclosures
6 of 6 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-01-28 | EVP, Ops & Clinical Research Sampath Anand | sold | $900K | SEC ↗ |
| 2026-01-28 | EVP, Ops & Clinical Research Sampath Anand | sold | $1.6M | SEC ↗ |
| 2026-01-28 | EVP, Ops & Clinical Research Sampath Anand | sold | $27K | SEC ↗ |
| 2025-08-13 | Director Brennan Michelle | bought | $16K | SEC ↗ |
| 2025-08-12 | Director Brennan Michelle | bought | $15K | SEC ↗ |
| 2025-08-11 | Director Jellison William R | bought | $438K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals